https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=MDA-19
MDA-19 - 版本历史
2026-07-17T12:35:23Z
在这个wiki上该页的修订历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=MDA-19&diff=4614096&oldid=prev
imported>Innerstream 来自 2026年3月1日 (日) 17:01
2026-03-01T17:01:58Z
<p></p>
<p><b>新页面</b></p><div>{{Drugbox<br />
| Verifiedfields = changed<br />
| verifiedrevid = 458773535<br />
| IUPAC_name = (3Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide<br />
| image = MDA-19.svg<br />
| width = 175<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --><br />
| pregnancy_US = <!-- A / B / C / D / X --><br />
| pregnancy_category = <br />
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --><br />
| legal_BR = F2<br />
| legal_BR_comment = <ref>{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-07-24 |title=RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |url-status=live |archive-url=https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |archive-date=2023-08-27 |access-date=2023-08-27 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-07-25}}</ref><br />
| legal_CA = Schedule II<br />
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --><br />
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --><br />
| legal_status = <br />
| routes_of_administration =<br />
<br />
<!--Pharmacokinetic data--><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion =<br />
<br />
<!--Identifiers--><br />
| CAS_number_Ref = {{cascite|correct|CAS}}<br />
| CAS_number = 1048973-47-2<br />
| CAS_supplemental = <br />{{CAS|1104302-26-2}} (alternative)<br />
| UNII_Ref = {{fdacite|correct|FDA}}<br />
| UNII = X83OI5CX2U <br />
| ATC_prefix = <br />
| ATC_suffix = <br />
| PubChem = 25034599<br />
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}<br />
| DrugBank = <br />
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}<br />
| ChemSpiderID = 24689676<br />
<br />
<!--Chemical data--><br />
| C=21 | H=23 | N=3 | O=2 <br />
| smiles = O=C(C1=CC=CC=C1)N/N=C(C2=CC=CC=C2N3CCCCCC)\C3=O<br />
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}<br />
| StdInChI = 1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14H,2-4,10,15H2,1H3,(H,23,25)/b22-19-<br />
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}<br />
| StdInChIKey = ZGQHMZCITJHYOW-QOCHGBHMSA-N<br />
}}<br />
'''{{PAGENAME}}'''（也称为'''BZO-HEXOXIZID'''）是一种含氮[[有机化合物]]，化学式[[C21H23N3O2|{{chem2|C21H23N3O2}}]]，可作为[[大麻素受体]]CB2的强效选择性[[激动剂]]<ref>{{Cite web |title=Systematic Naming for MDA 19 |url=https://www.caymanchem.com/literature/systematic-naming-for-mda-19 |website=www.caymanchem.com |language=en |access-date=2025-03-22}}</ref><ref>{{Cite web|url=https://www.npsdiscovery.org/new-systematic-naming-for-synthetic-cannabinoid-mda-19-and-its-related-analogues-bzo-hexoxizid-5f-bzo-poxizid-and-bzo-poxizid/|title = New Systematic Naming for Synthetic Cannabinoid "MDA-19" and its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZID|date = 31 August 2021}}</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
[[Category:大麻素]]</div>
imported>Innerstream